SK Capital enters exclusive talks to acquire Lisi Medical from LISI Group

SK Capital negotiating with LISI Group: ©Wladimir1804 - stock.adobe.com

Private investment firm SK Capital Partners announced it has entered exclusive negotiations to acquire the medical division of France-based LISI Group, a deal that would expand the firm’s footprint in the life sciences contract development and manufacturing (CDMO) sector.

Lisi Medical, the division in question, specializes in producing high-precision metal components and assemblies for global medical device manufacturers. Its offerings include surgical instruments used in minimally invasive and robotic-assisted procedures, as well as orthopedic implants. The company operates four manufacturing sites—two in Minnesota and two in France—with expertise in machining, forging, and automated production.

The proposed transaction remains subject to antitrust and foreign investment approvals, as well as consultations with employee representative bodies. The deal is expected to close in the second half of 2025.

“We feel privileged to partner with LISI Group to acquire Lisi Medical, whose deep engineering heritage and cutting-edge manufacturing technologies enable it to serve as a critical solutions provider for the world’s largest MedTech OEM customers,” said Josh Lieberman, principal at SK Capital. “We look forward to working with Lisi Medical’s management team to accelerate the company’s growth.”

LISI Group has owned the medical division for 14 years. Emmanuel Viellard, CEO of LISI Group, said the time was right to hand off the business to a firm that can guide its next stage.

“We are now looking forward to partner with SK Capital and boost Lisi Medical’s next development phase,” Viellard said. “Their strong track record in the life sciences sector and proven experience in France provide the essential strategic foresight and financial power to support the company going forward.”

SK Capital said the acquisition would complement its existing portfolio and aligns with its strategy of transforming carved-out businesses into independent growth platforms.